End-of-Day and Historical Options Data for US Stocks Learn more

Treace Medical Concepts Inc (TMCI NASDAQ) stock market data APIs

$3.3317 0.06(1.8%)
as of November 12, 2025
Try our APIs with free plan!

Treace Medical Concepts Inc Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG00GQK**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000163**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Prev. Close 3.3317
Open 3.392
High 3.6193
Low 3.3115
52 wk Range 3.31-10.79
Market Cap 212 M
Shares Outstanding 63 718 K
Revenue 219 M
EPS -0.2216
Beta 0.688

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Treace Medical Concepts Inc (top by weight)

Ticker
100-day Price Change
Weight
VRTGX.US Vanguard Russell 2000 Growth Index Fund Institutional Shares
41.93 (10.3%)
0.02
VTWG.US Vanguard Russell 2000 Growth Index Fund ETF Shares
22.09 (10.34%)
0.02
IHI.US iShares U.S. Medical Devices ETF
2.77 (4.59%)
0.02
IWO.US iShares Russell 2000 Growth ETF
30.18 (10.31%)
0.01
VRTIX.US Vanguard Russell 2000 Index Fund Institutional Shares
35.86 (10.52%)
0.01
VTWO.US Vanguard Russell 2000 Index Fund ETF Shares
9.49 (10.66%)
0.01
VHT.US Vanguard Health Care Index Fund ETF Shares
40.34 (16.52%)
0.01
IWM.US iShares Russell 2000 ETF
23.41 (10.63%)
0.01
ITOT.US iShares Core S&P Total U.S. Stock Market ETF
12.08 (8.82%)
0.00
VRTTX.US Vanguard Russell 3000 Index Fund Institutional Shares
47.28 (8.83%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Treace Medical Concepts Inc data using free add-ons & libraries


Get Treace Medical Concepts Inc Fundamental Data

Treace Medical Concepts Inc Fundamental data includes:

  • Net Revenue: 219 M
  • EBITDA: -39 331 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Treace Medical Concepts Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-11-11
  • EPS/Forecast: -0.2755
GET THE PACKAGE

Get Treace Medical Concepts Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Treace Medical Concepts Inc News

Looking at the Narrative for Treace Medical Concepts After Analyst Revisions and Growth Concerns New

Looking at the Narrative for Treace Medical Concepts After Analyst Revisions and Growth Concerns

Treace Medical Concepts has recently seen its consensus analyst price target cut from $8.58 to $6.56, reflecting a notable reduction in perceived fair value. While analyst notes highlight encouraging ...

Treace Announces Participation in Two Upcoming Investor Conferences

Treace Announces Participation in Two Upcoming Investor Conferences

PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in t...

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shar...

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of ...

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.